ArticleCancers2026

Safety and Treatment Discontinuation of Novel Hormonal Therapies in Metastatic Hormone-Sensitive Prostate Cancer: An Exploratory Real-World Study.

Irene Millan-Ramos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.